Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: ALXN1840 Wilson Phase III met primary endpoint
Investegate announcements from AstraZeneca PLC, ALXN1840 Wilson Phase III met primary endpoint
Source: investegate.co.uk
Stay updated with breaking news from Focus Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from AstraZeneca PLC, ALXN1840 Wilson Phase III met primary endpoint
Positive high-level results from the FoCus Phase III trial in Wilson disease showed ALXN1840 met the primary endpoint with a statistically significant...